April Capell

April Capell has over 18 years of experience in the biopharmaceutical industry. Their most recent position is as an Associate Director of Clinical Science at Harpoon Therapeutics, which they started in April 2023. Prior to that, they worked at Aptose Biosciences, Inc. from March 2022 to April 2023, where they served as a Clinical Development Manager in Medical Management and also as a Clinical Data Manager in Biometrics from May 2021 to March 2022. In November 2021 to January 2022, they took on a special assignment as a Study Execution Manager in Clinical Operations. From June 2020 to May 2021, they held the role of Clinical Study Manager, overseeing a team of Monitoring CRAs. Before that, April worked as a Senior Clinical Research Associate at inVentiv Health Clinical from August 2016 to February 2019. April also has freelance experience as a Medical Writer and Clinical Monitor at AML Consulting, LLC from September 2015 to August 2016. April started their career as a Senior CRA at PPD from October 2012 to September 2015 and held various roles at Novartis from September 2007 to October 2012, including Hematology/Oncology SWAT Senior CRA and Hematology/Oncology CRA. April also has experience as a CRA providing service to Novartis Oncology at Top Echelon Contracting, Inc. from August 2006 to September 2007. April began their career as a Hematology CRA at Chiron Corporation from October 2005 to August 2006 and as a Clinical Research Coordinator at Dow Pharmaceutical Sciences from May 2003 to October 2005. April started their career as a Clinical Research Assistant in the Department of Nutrition at UC Davis from January 2003 to May 2003.

April Capell has a Bachelor of Science (B.S.) degree in Cell Biology from the University of California, Davis. April also holds a Master of Science (MS) degree in Pharmaceutical Chemistry from the University of Florida, which they completed in 2017.